Common Stock, Shares, Outstanding of Cidara Therapeutics, Inc. from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Cidara Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2014 to 30 Sep 2025.
  • Cidara Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 29,335,397, a 316% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Cidara Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 29,335,397 +22,288,764 +316% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 23,234,839 +18,665,848 +409% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 12,209,150 +7,647,454 +168% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 10,946,635 +6,416,522 +142% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 7,046,633 -83,369,311 -92% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 4,568,991 -85,682,755 -95% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 4,561,696 -85,462,866 -95% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 4,530,113 -67,940,327 -94% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 90,415,944 +19,234,747 +27% 30 Sep 2023 10-K 22 Apr 2024 2023 FY
Q2 2023 90,251,746 +21,013,238 +30% 30 Jun 2023 10-K 22 Apr 2024 2023 FY
Q1 2023 90,024,562 +20,975,315 +30% 31 Mar 2023 10-K 22 Apr 2024 2023 FY
Q4 2022 72,470,440 +4,606,766 +6.8% 31 Dec 2022 10-K 22 Apr 2024 2023 FY
Q3 2022 71,181,197 +21,559,654 +43% 30 Sep 2022 10-K 22 Apr 2024 2023 FY
Q2 2022 69,238,508 +19,732,240 +40% 30 Jun 2022 10-K 22 Apr 2024 2023 FY
Q1 2022 69,049,247 +20,760,577 +43% 31 Mar 2022 10-K 22 Apr 2024 2023 FY
Q4 2021 67,863,674 +22,987,266 +51% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q3 2021 49,621,543 +5,685,517 +13% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 49,506,268 +7,487,073 +18% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 48,288,670 +7,729,159 +19% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 44,876,408 +11,037,942 +33% 31 Dec 2020 10-K 07 Mar 2022 2021 FY
Q3 2020 43,936,026 +10,929,746 +33% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 42,019,195 +15,251,206 +57% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 40,559,511 +13,917,660 +52% 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q4 2019 33,838,466 +6,022,452 +22% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 33,006,280 +5,254,867 +19% 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 26,767,989 -910,181 -3.3% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 26,641,851 +6,106,858 +30% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 27,816,014 +7,290,326 +36% 31 Dec 2018 10-K 04 Mar 2020 2019 FY
Q3 2018 27,751,413 +10,885,676 +65% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 27,678,170 +10,817,399 +64% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 20,534,993 +3,730,272 +22% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 20,525,688 +3,752,456 +22% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q3 2017 16,865,737 +2,949,753 +21% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 16,860,771 +2,960,195 +21% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 16,804,721 +2,964,929 +21% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 16,773,232 +2,986,947 +22% 31 Dec 2016 10-K 27 Feb 2018 2017 FY
Q3 2016 13,915,984 +219,698 +1.6% 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 13,900,576 +301,883 +2.2% 30 Jun 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 13,839,792 +12,692,724 +1107% 31 Mar 2016 10-Q 12 May 2016 2016 Q1
Q4 2015 13,786,285 +12,653,547 +1117% 31 Dec 2015 10-K 15 Mar 2017 2016 FY
Q3 2015 13,696,286 30 Sep 2015 10-Q 16 Nov 2015 2015 Q3
Q2 2015 13,598,693 30 Jun 2015 10-Q 11 Aug 2015 2015 Q2
Q1 2015 1,147,068 31 Mar 2015 10-Q 21 May 2015 2015 Q1
Q4 2014 1,132,738 31 Dec 2014 10-K 18 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.